ID   PLPP2_RAT               Reviewed;         276 AA.
AC   Q8K593;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   29-MAY-2024, entry version 124.
DE   RecName: Full=Phospholipid phosphatase 2 {ECO:0000305};
DE            EC=3.1.3.- {ECO:0000250|UniProtKB:O43688};
DE            EC=3.1.3.4 {ECO:0000250|UniProtKB:O43688};
DE   AltName: Full=Lipid phosphate phosphohydrolase 2;
DE   AltName: Full=PAP2-gamma;
DE            Short=PAP2-G;
DE   AltName: Full=Phosphatidate phosphohydrolase type 2c;
DE   AltName: Full=Phosphatidic acid phosphatase 2c;
DE            Short=PAP-2c;
DE            Short=PAP2c;
GN   Name=Plpp2 {ECO:0000312|RGD:628893}; Synonyms=Lpp2, Ppap2c;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Lung;
RA   Zhao L., Nanjundan M., Possmayer F.;
RT   "Expression of lipid phosphate phosphohydrolase isoforms in rat lung
RT   development.";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11704545; DOI=10.1152/ajplung.2001.281.6.l1484;
RA   Nanjundan M., Possmayer F.;
RT   "Molecular cloning and expression of pulmonary lipid phosphate
RT   phosphohydrolases.";
RL   Am. J. Physiol. 281:L1484-L1493(2001).
RN   [4]
RP   FUNCTION.
RX   PubMed=16467304; DOI=10.1074/jbc.m511710200;
RA   Morris K.E., Schang L.M., Brindley D.N.;
RT   "Lipid phosphate phosphatase-2 activity regulates S-phase entry of the cell
RT   cycle in Rat2 fibroblasts.";
RL   J. Biol. Chem. 281:9297-9306(2006).
CC   -!- FUNCTION: Magnesium-independent phospholipid phosphatase that catalyzes
CC       the dephosphorylation of a variety of glycerolipid and sphingolipid
CC       phosphate esters including phosphatidate/PA, lysophosphatidate/LPA,
CC       sphingosine 1-phosphate/S1P and ceramide 1-phosphate/C1P. Has no
CC       apparent extracellular phosphatase activity and therefore most probably
CC       acts intracellularly. Also acts on N-oleoyl ethanolamine phosphate/N-
CC       (9Z-octadecenoyl)-ethanolamine phosphate, a potential physiological
CC       compound. Through dephosphorylation of these bioactive lipid mediators
CC       produces new bioactive compounds and may regulate signal transduction
CC       in different cellular processes (By similarity). Indirectly regulates,
CC       for instance, cell cycle G1/S phase transition through its phospholipid
CC       phosphatase activity (PubMed:16467304). {ECO:0000250|UniProtKB:O43688,
CC       ECO:0000269|PubMed:16467304}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphate + H2O = a 1,2-diacyl-sn-
CC         glycerol + phosphate; Xref=Rhea:RHEA:27429, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:43474, ChEBI:CHEBI:58608; EC=3.1.3.4;
CC         Evidence={ECO:0000250|UniProtKB:O43688};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:27430;
CC         Evidence={ECO:0000250|UniProtKB:O43688};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphate + H2O = 1,2-
CC         dihexadecanoyl-sn-glycerol + phosphate; Xref=Rhea:RHEA:43236,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:72859,
CC         ChEBI:CHEBI:82929; Evidence={ECO:0000250|UniProtKB:O43688};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43237;
CC         Evidence={ECO:0000250|UniProtKB:O43688};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate + H2O = 1,2-
CC         di-(9Z-octadecenoyl)-sn-glycerol + phosphate; Xref=Rhea:RHEA:43244,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:52333,
CC         ChEBI:CHEBI:74546; Evidence={ECO:0000250|UniProtKB:O43688};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43245;
CC         Evidence={ECO:0000250|UniProtKB:O43688};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + monoacyl-sn-glycero-3-phosphate = a monoacylglycerol +
CC         phosphate; Xref=Rhea:RHEA:46736, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:17408, ChEBI:CHEBI:43474, ChEBI:CHEBI:77589;
CC         Evidence={ECO:0000250|UniProtKB:O43688};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46737;
CC         Evidence={ECO:0000250|UniProtKB:O43688};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-sn-glycero-3-phosphate + H2O = (9Z-
CC         octadecenoyl)-glycerol + phosphate; Xref=Rhea:RHEA:50884,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:75937,
CC         ChEBI:CHEBI:84973; Evidence={ECO:0000250|UniProtKB:O43688};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50885;
CC         Evidence={ECO:0000250|UniProtKB:O43688};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + sphing-4-enine 1-phosphate = phosphate + sphing-4-enine;
CC         Xref=Rhea:RHEA:27518, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57756, ChEBI:CHEBI:60119;
CC         Evidence={ECO:0000250|UniProtKB:O43688};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:27519;
CC         Evidence={ECO:0000250|UniProtKB:O43688};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-acylsphing-4-enine 1-phosphate + H2O = an N-acylsphing-4-
CC         enine + phosphate; Xref=Rhea:RHEA:33743, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:52639, ChEBI:CHEBI:57674;
CC         Evidence={ECO:0000250|UniProtKB:O43688};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33744;
CC         Evidence={ECO:0000250|UniProtKB:O43688};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-(octanoyl)-sphing-4-enine-1-phosphate = N-
CC         octanoylsphing-4-enine + phosphate; Xref=Rhea:RHEA:62040,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:45815,
CC         ChEBI:CHEBI:85376; Evidence={ECO:0000250|UniProtKB:O43688};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62041;
CC         Evidence={ECO:0000250|UniProtKB:O43688};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-(9Z-octadecenoyl)-ethanolamine phosphate = N-(9Z-
CC         octadecenoyl) ethanolamine + phosphate; Xref=Rhea:RHEA:62160,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:71466,
CC         ChEBI:CHEBI:145465; Evidence={ECO:0000250|UniProtKB:O43688};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62161;
CC         Evidence={ECO:0000250|UniProtKB:O43688};
CC   -!- ACTIVITY REGULATION: Magnesium-independent phospholipid phosphatase.
CC       Insensitive to N-ethylmaleimide. {ECO:0000250|UniProtKB:O43688}.
CC   -!- PATHWAY: Lipid metabolism; phospholipid metabolism.
CC       {ECO:0000250|UniProtKB:O43688}.
CC   -!- SUBUNIT: Forms functional homodimers and homooligomers. Can also form
CC       heterooligomers with PLPP1 and PLPP3. {ECO:0000250|UniProtKB:O43688}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:O43688}; Multi-
CC       pass membrane protein {ECO:0000255}. Cell membrane
CC       {ECO:0000250|UniProtKB:O43688}; Multi-pass membrane protein
CC       {ECO:0000255}. Early endosome membrane {ECO:0000250|UniProtKB:O43688};
CC       Multi-pass membrane protein {ECO:0000255}. Endoplasmic reticulum
CC       membrane {ECO:0000250|UniProtKB:O43688}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in the brain.
CC       {ECO:0000269|PubMed:11704545}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:O43688}.
CC   -!- SIMILARITY: Belongs to the PA-phosphatase related phosphoesterase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF503611; AAM28632.1; -; mRNA.
DR   EMBL; BC062088; AAH62088.1; -; mRNA.
DR   RefSeq; NP_640345.1; NM_139252.1.
DR   AlphaFoldDB; Q8K593; -.
DR   STRING; 10116.ENSRNOP00000000193; -.
DR   GlyCosmos; Q8K593; 2 sites, No reported glycans.
DR   GlyGen; Q8K593; 2 sites.
DR   PhosphoSitePlus; Q8K593; -.
DR   PaxDb; 10116-ENSRNOP00000000193; -.
DR   Ensembl; ENSRNOT00000000193.4; ENSRNOP00000000193.1; ENSRNOG00000000177.4.
DR   Ensembl; ENSRNOT00065035418; ENSRNOP00065028526; ENSRNOG00065020855.
DR   GeneID; 246115; -.
DR   KEGG; rno:246115; -.
DR   UCSC; RGD:628893; rat.
DR   AGR; RGD:628893; -.
DR   CTD; 8612; -.
DR   RGD; 628893; Plpp2.
DR   eggNOG; KOG3030; Eukaryota.
DR   GeneTree; ENSGT00940000155885; -.
DR   HOGENOM; CLU_021458_3_1_1; -.
DR   InParanoid; Q8K593; -.
DR   OrthoDB; 25293at2759; -.
DR   PhylomeDB; Q8K593; -.
DR   TreeFam; TF316040; -.
DR   Reactome; R-RNO-9845614; Sphingolipid catabolism.
DR   UniPathway; UPA00085; -.
DR   PRO; PR:Q8K593; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000000177; Expressed in jejunum and 18 other cell types or tissues.
DR   GO; GO:0005901; C:caveola; ISS:UniProtKB.
DR   GO; GO:0005769; C:early endosome; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0106235; F:ceramide-1-phosphate phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0008195; F:phosphatidate phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0042392; F:sphingosine-1-phosphate phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0006672; P:ceramide metabolic process; ISS:UniProtKB.
DR   GO; GO:0046839; P:phospholipid dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0006644; P:phospholipid metabolic process; ISS:UniProtKB.
DR   GO; GO:1902806; P:regulation of cell cycle G1/S phase transition; IMP:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   GO; GO:0006670; P:sphingosine metabolic process; ISS:UniProtKB.
DR   CDD; cd03384; PAP2_wunen; 1.
DR   Gene3D; 1.20.144.10; Phosphatidic acid phosphatase type 2/haloperoxidase; 1.
DR   InterPro; IPR036938; P_Acid_Pase_2/haloperoxi_sf.
DR   InterPro; IPR000326; P_Acid_Pase_2/haloperoxidase.
DR   InterPro; IPR043216; PA_PP_rel.
DR   PANTHER; PTHR10165; LIPID PHOSPHATE PHOSPHATASE; 1.
DR   PANTHER; PTHR10165:SF25; PHOSPHOLIPID PHOSPHATASE 2; 1.
DR   Pfam; PF01569; PAP2; 1.
DR   SMART; SM00014; acidPPc; 1.
DR   SUPFAM; SSF48317; Acid phosphatase/Vanadium-dependent haloperoxidase; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Endoplasmic reticulum; Endosome; Glycoprotein; Hydrolase;
KW   Lipid metabolism; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..276
FT                   /note="Phospholipid phosphatase 2"
FT                   /id="PRO_0000220911"
FT   TOPO_DOM        1..4
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        5..25
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        26..51
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        52..72
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        73..87
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        88..108
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        109..161
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        162..182
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        183..189
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        190..210
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        211..225
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        226..246
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        247..276
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REGION          117..125
FT                   /note="Phosphatase sequence motif I"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   REGION          164..167
FT                   /note="Phosphatase sequence motif II"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   REGION          212..223
FT                   /note="Phosphatase sequence motif III"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   REGION          252..276
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        167
FT                   /note="Proton donors"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   ACT_SITE        219
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   SITE            223
FT                   /note="Stabilizes the active site histidine for
FT                   nucleophilic attack"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   CARBOHYD        139
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        155
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   276 AA;  31101 MW;  41A0E1243458E24C CRC64;
     MERRWVFVLL DVLCVLVASL PFIILTLVNA PYKRGFYCGD DSIRYPYRPD TITHGLMAGV
     IITATVVLVS SGEAYLVYTD RLYSRSDFNN YVAAIYKVLG TFLFGAAVSQ SLTDLAKYMI
     GRLRPSFLAV CDPDWSRVNC SGYVQVEVCR GSPANVTEAR LSFYSGHSSF GMYCMLFLAL
     YVQARLCWKW ARLLRPTVQF FLVAFAIYVG YTRVSDNKHH WSDVLVGLLQ GALVACLTVC
     YVSDFFKSRP PQSCQENEES ERKPSLSLTL TLGDRP
//
